Home Politics Religion Media Biz Society Tech Travel Books Intl. Autos Automobiles
                        Aviation   Pharma   About Us   Feedback   Links


Diverticulitis orally dissolving pill from KV Pharma's  hits the market



17 September,2005: Hyoscyamine quick dissolving tablets for diverticulitis are now available in the US market.

Hyoscyamine Sulfate is an anti-spasmodic/anticholinergic product indicated for the treatment of diverticulitis and a host of other lower intestinal disorders like spastic colitis, spastic bladder, cystitis, pylorospasm and associated abdominal cramps.

The orally dissolving pills will be utilizing OraQuick delivery system developed by KV Pharmaceutical Company. These tablets disintegrate and dissolve on the tongue within seconds after ingestion. Pills can be taken orally without water. 

The delivery system can hold a large "payload" of active drugs and is a durable oral tablet that does not require special packaging requirements.

KV Pharmaceutical Company is a specialty pharmaceutical company that develops, manufactures, markets and acquires technology-distinguished branded and generic/non-branded prescription pharmaceutical products. The company markets its technology distinguished products through Ethex Corporation and Ther-Rx Corporation. In 1990, KV established Ethex Corporation to develop and market generic and non-branded drugs that could benefit from the application of KV's drug delivery technologies. In 1999, KV established Ther-Rx Corporation to develop and market branded prescription products utilizing these proprietary technologies as well. Today, KV offers 15 drug delivery technologies, in four principal areas, used in most of the company's more than 100 generic and non-branded drugs and 13 branded drugs that are sold today. KV has consistently ranked as one of America’s fastest growing small companies, most recently by Forbes in its November 2004 issue.



   Pharma Home

Chinese herbal products could be dangerous: UK 

Knock, knock! It's bird flu at the door

Spider anti-venom to be stocked in UAE hospital 

US may ban animal protein in cattle feed to safeguard against mad cow 

Dr Reddy's nizatidine generic gets FDA nod

Late-onset Pompe disease drug goes on trial

First biologic to treat ulcerative colitis gets US FDA okay

Diverticulitis orally dissolving pill from KV Pharma's  hits the market

Impax delisted from Nasdaq

US FDA okays Lupin's cephalexin

Hepatitis C combo therapy to get priority review in Japan

Lung cancer vaccine trials promising: Introgen

Sugar-free pill Actiq for cancer pain

39 drug firms sued over price rigging in California

Anti fungal terbinafine launched in Europe: Actavis

HIV entry blocking drug data encouraging: Progenics

Allegra generic to be launched in US

Long-acting pain drug data positive: Pain Therapeutics

New kidney cancer drug seeks EU nod

Inhaled insulin may get US FDA clearance

A vaccine against fungus is on way

Enzyme stops progression of HIV in survivors, confirms study

Aclasta found faster-acting in Paget's disease treatment

Beta blocker can start therapy in heart failure: Merck

Halobetasol generic launched in US

Anemia drug darbepoetin's late-stage studies begin: Amgen

Cholesterol generic gets marketing nod in US: Par

Aricept for severe Alzheimer’s disease too: Eisai

Bone regeneration trials begin in US:Mesoblast

New dye to detect early Alzheimer's

Breast forming gene discovered

Thyroid drug to be supplied by IVAX in US

Rituxan, cancer drug can treat rheumatoid arthritis

Yasminelle, low-dose oral contraceptive approved in the Netherlands

Fluarix, anti-flu shot by Glaxo approved

Increlex, drug to treat `abnormally short’ kids approved in US

Anti-HIV drugs prices cut: Gilead

US FDA approves Takeda’s drug combo for type 2 diabetes

Novartis’ drug for breast cancer recurrence to be given priority review in US

US puts off decision on contraceptive pill again

Shire’s ADHD drug Adderall back on list in Canada

WHO calls for emergency action to halt TB in Africa

Some of the Vioxx suits may be settled: Merck

Nasdaq delists Able on bankruptcy filing

Hospira ships ceftriaxone generics to US

Renovis stops sciatica drug studies


Home Politics Religion Media Biz Society Tech Travel Books Intl. Autos Automobiles
                        Aviation   Pharma   About Us   Feedback   Links

Latest updates    Contact Us - Feedback    About Us